Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal antibody responses after seasonal RTS,S/AS01E vaccination with or without seasonal malaria chemoprevention in Malian children
PACTR202409856142141Not yet recruiting
- Sponsor
- Faculty of Pharmacy, University of Sciences, Techniques and Technologies of Bamako
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of RTS,S in malaria (3 arms), sponsored by Faculty of Pharmacy, University of Sciences, Techniques and Technologies of Bamako. Primary endpoint: Natural log mean fluorescent intensity of antibody responses. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202409856142141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409856142141.